Clincosm LogoSign in Get a demo

Non Small Cell Lung Cancer

Showing NaN - NaN of 58
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer

Recruiting
  • Non Small Cell Lung Cancer
  • Observational
  • New York, New York
    Columbia University Irving Medical Center, Herbert Irving Compre
Apr 7, 2022

Non Small Cell Lung Cancer, Lung Cancer, Nsclc Trial in United States (Radiation Therapy, Durvalumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Miami, Florida
  • +8 more
Mar 30, 2022

Non Small Cell Lung Cancer Trial in United States (Aglatimagene besadenovec)

Recruiting
  • Non Small Cell Lung Cancer
  • Aglatimagene besadenovec
  • Farmington, Connecticut
  • +10 more
Mar 28, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Nivolumab, Cisplatin, Vinorelbine)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Nivolumab
  • +8 more
  • Glendale, Arizona
  • +135 more
Feb 28, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

Recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Irvine, California
  • +15 more
Mar 9, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Necitumumab, Gemcitabine, Cisplatin)

Active, not recruiting
Has Results
  • Non Small Cell Lung Cancer
  • Necitumumab
  • +2 more
  • Chandler, Arizona
  • +181 more
Feb 4, 2022

Non Small Cell Lung Cancer, KRAS Gene Mutation Trial in United States (Trametinib 0.5 mg, Trametinib 1 MG, Trametinib 1.5 MG)

Completed
  • Non Small Cell Lung Cancer
  • KRAS Gene Mutation
  • Trametinib 0.5 mg
  • +5 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 7, 2022

Melanoma, Non Small Cell Lung Cancer Trial in United States (enoblituzumab plus ipilimumab)

Completed
  • Melanoma
  • Non Small Cell Lung Cancer
  • enoblituzumab plus ipilimumab
  • Los Angeles, California
  • +9 more
Feb 4, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Ovarian Cancer, Head Neck Cancer, Non Small Cell Lung Cancer Trial in United States (TJ004309)

Recruiting
  • Ovarian Cancer
  • +5 more
  • Tucson, Arizona
  • +17 more
Jan 18, 2022

Melanoma, Head Neck Cancer, Non Small Cell Lung Cancer Trial in United States (Enoblituzumab, Pembrolizumab, MGA012)

Completed
  • Melanoma
  • +3 more
  • Enoblituzumab
  • +2 more
  • Scottsdale, Arizona
  • +19 more
Sep 22, 2021

Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma Trial in Australia, United States (GRT-C901,

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • GRT-C901
  • +3 more
  • Phoenix, Arizona
  • +10 more
Aug 31, 2021

Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)

Recruiting
  • Cancer, Metastatic
  • +42 more
  • Clinical Trial Matching
  • New York, New York
    Massive Bio, Inc
May 21, 2021

Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early

Withdrawn
  • NSCLC
  • Non Small Cell Lung Cancer
  • Cesium-131 Brachytherapy Seed
  • New York, New York
    Weill Cornell Medical College
Mar 25, 2021

Solid Tumor, Adult, Triple Negative Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (AVID100 IV)

Terminated
  • Solid Tumor, Adult
  • +3 more
  • AVID100 IV
  • New Haven, Connecticut
  • +9 more
Mar 22, 2021

Non Small Cell Lung Cancer, Cancer Trial in United States (Venetoclax, Pembrolizumab)

Terminated
  • Non Small Cell Lung Cancer
  • Cancer
  • Birmingham, Alabama
  • +38 more
Feb 10, 2021

Breast Cancer, Non Small Cell Lung Cancer, GastroEsophageal Cancer Trial in Belgium, United States (ADCT-502)

Terminated
Has Results
  • Breast Cancer
  • +3 more
  • Palo Alto, California
  • +4 more
Jan 6, 2021

Non Small Cell Lung Cancer, Ovarian Cancer, RET Gene Mutation Trial in New York (RXDX-105)

Completed
  • Non Small Cell Lung Cancer
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center 1275 York Avenue
Sep 30, 2020

A Study of Personalized Neoantigen Cancer Vaccines

Completed
  • Non Small Cell Lung Cancer
  • +4 more
  • Blood collection for research (next-generation sequencing [NGS])
  • Blood collection for research (HLA typing)
  • Chicago, Illinois
  • +4 more
Sep 10, 2020

Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies

Withdrawn
  • Non Small Cell Lung Cancer
  • Pre-Treatment Biopsy
  • +3 more
  • Basking Ridge, New Jersey
  • +5 more
Aug 27, 2020

Non Small Cell Lung Cancer Trial in Palo Alto, Boston, New York (Afatinib)

Unknown status
  • Non Small Cell Lung Cancer
  • Palo Alto, California
  • +3 more
Jul 1, 2020

Advanced Solid Tumors, Pancreatic Cancer, Non Small Cell Lung Cancer Trial in Canada, Spain, United States (MSC-1)

Terminated
  • Advanced Solid Tumors
  • +3 more
  • MSC-1
  • Scottsdale, Arizona
  • +6 more
Jan 2, 2020

Lung Cancer, Non Small Cell Lung Cancer Trial in United States (apricoxib, Placebo, Docetaxel or Pemetrexed)

Completed
Has Results
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Los Angeles, California
  • +11 more
Oct 15, 2019

NSCLC, Non Small Cell Lung Cancer Trial in Worldwide (OSI-906, Erlotinib, Placebo)

Completed
  • NSCLC
  • Non Small Cell Lung Cancer
  • La Jolla, California
  • +28 more
Jan 21, 2019

Non Small Cell Lung Cancer, Lung Cancer Trial in New York (erlotinib, Pemetrexed, Cisplatin)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Lung Cancer
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Dec 11, 2017